Association of beta (1)-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension

Clinical Biochemistry

Volumn 41, Issue 10-11, 2008, Pages 773-778

  Fu, Chunyan ^a   Wang, Hu ^a   Wang, Shuxia ^a   Shi, Yi ^a   Zhou, Xianliang ^a   Sun, Kai ^a   Chen, Jingzhou ^a   Song, Xiaodong ^a   Xue, Hao ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Beta (1) adrenergic receptor; Hypertension; Left ventricular hypertrophy; Polymorphism

Indexed keywords

ARGININE; BETA 1 ADRENERGIC RECEPTOR; GLYCINE; SERINE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHINESE; CLINICAL FEATURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THICKNESS;

AGED; AMINO ACID SUBSTITUTION; ARGININE; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; GLYCINE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA-1; RISK ASSESSMENT;

EID: 46549083283     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.02.002     Document Type: Article

References (33)

1. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
2. Nunez D.J., Clifford C.P., al-Mahdawi S., and Dutka D. Hypertensive cardiac hypertrophy-Is genetic variance the missing link?. Br J Clin Pharmacol 42 (1996) 107-117
3. Verhaaren H.A., Schieken R.M., Mosteller M., Hewitt J.K., Eaves L.J., and Nance W.E. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am J Cardiol 68 (1991) 661-668
4. Tanase H., Yamori Y., Hansen C.T., and Lovenberg W. Heart size in inbred strains of rats. Part 1. Genetic determination of the development of cardiovascular enlargement in rats. Hypertension 4 (1982) 864-872
5. Strader C.D., Fong T.M., Tota M.R., Underwood D., and Dixon R.A. Structure and function of G protein-coupled receptors. Annu Rev Biochem 63 (1994) 101-132
6. Engelhardt S., Hein L., Keller U., Klambt K., and Lohse M.J. Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Circ Res 90 (2002) 814-819
7. Iemitsu M., Miyauchi T., Maeda S., et al. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol 281 (2001) R2029-R2036
8. Bisognano J.D., Weinberger H.D., Bohlmeyer T.J., et al. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 32 (2000) 817-830
9. Engelhardt S., Hein L., Wiesmann F., and Lohse M.J. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 96 (1999) 7059-7064
10. Hoehe M.R., Otterud B., Hsieh W.T., et al. Genetic mapping of adrenergic receptor genes in humans. J Mol Med 73 (1995) 299-306
11. Maqbool A., Hall A.S., Ball S.G., and Balmforth A.J. Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet 353 (1999) 897
12. Mason D.A., Moore J.D., Green S.A., and Liggett S.B. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274 (1999) 12670-12674
13. Moore J.D., Mason D.A., Green S.A., Hsu J., and Liggett S.B. Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Hum Mutat 14 (1999) 271
14. Mialet Perez J., Rathz D.A., Petrashevskaya N.N., et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 9 (2003) 1300-1305
15. Iwai C., Akita H., Kanazawa K., et al. Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction. Am Heart J 146 (2003) 106-109
16. Shioji K., Kokubo Y., Mannami T., et al. Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study. Hypertens Res 27 (2004) 31-37
17. Bengtsson K., Melander O., Orho-Melander M., et al. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 104 (2001) 187-190
18. Sofowora G.G., Dishy V., Muszkat M., et al. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 73 (2003) 366-371
19. Terra S.G., Hamilton K.K., Pauly D.F., et al. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy. Pharmacogenet Genomics 15 (2005) 227-234
20. Magnusson Y., Levin M.C., Eggertsen R., et al. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy. Clin Pharmacol Ther 78 (2005) 221-231
21. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
22. Devereux R.B., and RM. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques (1995), Raven Press, New York 1969-85pp
23. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
24. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
25. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
26. Liu Z.Q., Liu J., Xiang Z.H., et al. Distributive characteristics of Ser49Gly and Gly389Arg genetic polymorphisms of beta1-adrenoceptor in Chinese Han and Dai populations. Acta Pharmacol Sin 27 (2006) 254-258
27. Bristow M.R. Why does the myocardium fail? Insights from basic science. Lancet 352 Suppl 1 (1998) SI8-SI14
28. Bristow M.R. Mechanistic and clinical rationales for using beta-blockers in heart failure. J Card Fail 6 (2000) 8-14
29. Naga Prasad S.V., Nienaber J., and Rockman H.A. Beta-adrenergic axis and heart disease. Trends Genet 17 (2001) S44-S49
30. Johnson M. The beta-adrenoceptor. Am J Respir Crit Care Med 158 (1998) S146-S153
31. Brodde O.E. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43 (1991) 203-242
32. Buxton I.L., and Brunton L.L. Direct analysis of beta-adrenergic receptor subtypes on intact adult ventricular myocytes of the rat. Circ Res 56 (1985) 126-132
33. Friddle C.J., Koga T., Rubin E.M., and Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci U S A 97 (2000) 6745-6750